The Effect of the 2009 USPSTF breast cancer screening recommendations on breast cancer in Michigan: A longitudinal study.

Autor: Caughran J; Comprehensive Breast Center, Mercy Health Saint Mary's, Grand Rapids, MI, USA., Braun TM; Rogel Cancer Center, University of Michigan, Ann Arbor, MI, USA., Breslin TM; Comprehensive Breast Program, Mercy Health St. Joseph, Ann Arbor, MI, USA., Smith DR; Physician Assistant Studies, Grand Valley State University, Allendale, MI, USA., Kreinbrink JL; Physician Assistant Studies, Grand Valley State University, Allendale, MI, USA., Parish GK; Physician Assistant Studies, Grand Valley State University, Allendale, MI, USA., Davis AT; Physician Assistant Studies, Grand Valley State University, Allendale, MI, USA., Bacon-Baguley TA; Physician Assistant Studies, Grand Valley State University, Allendale, MI, USA., Silver SM; Rogel Cancer Center, University of Michigan, Ann Arbor, MI, USA., Henry NL; Division of Oncology, University of Utah, Salt Lake City, UT, USA.
Jazyk: angličtina
Zdroj: The breast journal [Breast J] 2018 Sep; Vol. 24 (5), pp. 730-737. Date of Electronic Publication: 2018 May 21.
DOI: 10.1111/tbj.13034
Abstrakt: In 2009, the revised United States Preventive Services Task Force (USPSTF) guidelines recommended against routine screening mammography for women age 40-49 years and against teaching self-breast examinations (SBE). The aim of this study was to analyze whether breast cancer method of presentation changed following the 2009 USPSTF screening recommendations in a large Michigan cohort. Data were collected on women with newly diagnosed stage 0-III breast cancer participating in the Michigan Breast Oncology Quality Initiative (MiBOQI) registry at 25 statewide institutions from 2006 to 2015. Data included method of detection, cancer stage, treatment type, and patient demographics. In all, 30 008 women with breast cancer detected via mammogram or palpation with an average age of 60.1 years were included. 38% of invasive cancers were identified by palpation. Presentation with palpable findings decreased slightly over time, from 34.6% in 2006 to 28.9% in 2015 (P < .001). Over the 9-year period, there was no statistically significant change in rate of palpation-detected tumors for women age <50 years or ≥50 years (P = .27, .30, respectively). Younger women were more likely to present with palpable tumors compared to older women in a statewide registry. This rate did not increase following publication of the 2009 USPSTF breast cancer screening recommendations.
(© 2018 Wiley Periodicals, Inc.)
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje